Similar Stories to Phrma: Drug List Prices In Ads Would Be Confusing on Bing News

We want to provide cost information in a comprehensive fashion, writes Stephen J. Ubl, CEO of Pharmaceutical Research and Manufacturers of America.        

Topics:  commentary   
RELATED ARTICLES
    BING NEWS:
    • 25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says
      The number of U.S. patients currently starting the weight management drug Wegovy is "four times" the number in December 2023, the drugmaker said.
      05/4/2024 - 2:41 am | View Link
    • New Bill Seeks to End Drug Shortages
      The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers.
      05/3/2024 - 3:26 am | View Link
    • Proposed $10.50 fee on prescription drug purchases withers in one day in Arkansas
      State officials shelved a proposed regulation Thursday to add a $10.50 dispensing fee for every prescription filled in Arkansas.
      05/2/2024 - 10:16 pm | View Link
    • Senate Finance Committee introduces legislation aimed at fixing drug shortages
      The Senate Finance Committee introduced bipartisan legislation Friday aimed at preventing and reducing generic drug shortages by leveraging Medicare and Medicaid programs. The draft legislation ...
      05/2/2024 - 10:00 pm | View Link
    • Blockbuster weight-loss drug Wegovy's sales just doubled — and could heat up even more with a price cut
      Sales of Wegovy more than doubled in the first quarter year on year to $1.3 billion.
      05/2/2024 - 6:32 pm | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More Commentary News